Abstract. Active contractile pattern of the oviduct occurs during the periovulatory period for the movement of the gamete/embryo, which is strictly regulated by endocrine and paracrine/autocrine factors. In this review, an involvement of tumor necrosis factor α (TNFα) in the regulation of cow oviductal contraction is discussed. Oviductal epithelial cells express TNFα ligand and it's both receptor types; high expression during the follicular and postovulatory stages, while low expression during luteal stage and thus, TNFα system in the cow oviduct is most active during the periovularoty period. The immune cells present in large numbers in the oviduct during the periovulatory period of the estrus cycle, and these cells are also considered as another potential source for the TNFα in the oviduct. Using in vitro models, TNFα clearly stimulated local production and release of contraction related substances such as prostaglandins (PGs), endothelin-1 (ET-1) and angiotensin II (Ang II). Since these substances have been shown to activate directly the oviductal contraction in vitro, TNFα appears to stimulate the oviductal contraction during the periovulatory period and contribute to create an optimal local environment suitable for gamete/embryo transport. In addition, the ability of embryo to act as a source of TNFα in the oviduct cannot be excluded. To support this idea, the embryo at 2-4 cells stages indeed express TNFα, so that the minute quantities of TNFα secreted by the embryo may further acts locally to enhance the production of PG, ET-1 and Ang II in the oviduct, which may result in an active oviductal contraction in the microenvironment around the embryo. This may ensure the embryo to migrate into the uterus at the optimal time.
he oviduct plays a central role in the events of fertilization and early embryonic development by providing an environment that facilitates sperm transport and capacitation, and oocyte transport and maturation. The simultaneous opposite movements of gametes to the fertilization site and the subsequent passage of the embryo into the uterus at the precise developmental stage are essential steps for establishment of implantation [1, 2] . Active contractile patterns of the oviduct occur during the periovulatory period for the movement of the zygote, which are strictly regulated by endocrine and paracrine/autocrine factors. In this review, the possible involvement of tumor necrosis factor α (TNFα) in the regulation of cow oviductal contraction is discussed.
cytokine that mediates cell-to-cell communication. This cytokine was initially identified as an up-and down-regulator of immunologic, inflammatory and reparative host responses to injury. The existence of the bioactive form of this pro-inflammatory cytokine, as well as its binding sites in the various reproductive tissues have been reported [3] [4] [5] [6] [7] . The TNFα gene is expressed in mouse oviductal epithelial cells [7] and human oviductal fluid contains TNFα protein [6] . Moreover, the stage specific expressions of mRNA for TNFα, TNFα-R I and TNFα -R II were detected in the bovine oviductal epithelial cells by reverse transcriptionpolymerase chain reaction (RT-PCR) and proposed the possible involvement of TNFα in the control of cyclic oviductal contraction in the cow [8] . In addition, in the reproductive tract, a variety of immune cells are present and their number and distribution vary in a tissue-specific manner with the stage of the estrous cycle [4] . Thus, another potential source for the TNFα in the oviduct may be the immune cells present in the oviduct.
On the other hand, several reports reveled that the transoviductal stages of embryo is capable of r e l e a s i n g T N F α . T h e i d e n t i f i c a ti o n o f immunoreactive and bioactive TNFα within in the rat oocytes [9] and TNFα-R by rat blastocysts [10] were reported. In human embryo, mRNA for TNFα ligand and TNFα-R were expressed in a stage-specific manner [11] . In mammals, the embryo expresses TNFα-R whilst ligands are secreted by the supporting tissues of the oviduct and uterus, and in some cases, the embryo itself [12] . These findings suggest that TNFα bears a major role in the dynamic developmental events of pregnancy [13] . Moreover, we observed that the embryos surgically collected from the cow oviduct expressed mRNA for TNFα (unpublished data). Indeed, the quantities of TNFα secreted by the embryo is little when compared to the amounts present in the oviduct, however, this minute quantities of TNFα may act locally in the oviductal microenvironment around embryo and may be involved in the local oviductal contraction.
Changes of Tumor Necrosis Factor α Production in the Oviduct during the Estrous Cycle
In the bovine oviduct, a stage-specific mRNA expression for TNFα and it's both receptor types during the estrous cycle is well documented. The high expression of both TNFα receptor types and ligands was detected during the follicular and postovulatory stages, while low expression was detected during luteal stage [8] . It was also observed that in human endometrium, the highest levels of the immunohistochemical staining of TNFα specific polyclonal antibody was observed at the late secretory phase [14] , and in mouse uterus cytokine bioactivity was highest during proestrus and/or estrus [15] . Moreover, progesterone (P4) is identified as a potent inhibitor of TNFα mRNA expression and TNFα protein production in the endometrium of ruminants [3] and in activated mouse macrophages [16] . Thus, the low expression of TNFα and its receptor mRNA during the luteal phase of the estrus cycle might due to the inhibitory action of P 4 [8] . On the other hand, the high expression of TNFα ligand and receptor mRNA observed during the periovulatory period [8] might due to the presence of considerable amounts of estradiol 17β (E2) in the cow oviduct during this period [17] . These observations give good evidence that the TNFα system in the cow oviduct is most active during the periovularoty period.
Regulation of Oviductal Contraction during the Estrous Cycle
Studies on spontaneous oviduct contraction in the cow revealed low amplitude and frequency in motility during the luteal phase [18] , which gradually increased with the drop in serum P4 prior to estrus [19] . Both amplitude and frequency reach a maximum during estrus, but rapidly diminish over the next 3 days [18, 19] . These observations pr o vi d e ev id en ce t hat p att e rn s o f o v id uc t contraction during the periovulatory period are tempo ra lly a nd st rictly co ntr olled by lo ca l mechanisms that are responsive to the needs of the zygote.
The prostaglandins (PGs) play a major role in oviductal transport of gametes/embryo. The Eseries PGs relax, while F-series PG stimulate muscular activity of the oviduct [20] . Moreover, we recently reported that PG increased in vitro contractile amplitude of cow oviducts collected during follicular and postovulatory phases, but not during the estrous cycle [21] . The concentration of local oviductal PG [17] as well as it's receptor number [22] were highest during the periovulatory pe ri o d o f c o w o v id uc t s a nd c la i m ed t o be responsible for the peak oviductal contraction observed during this period [18, 23] .
Recent evidence in the cow sugges ts tha t endothelin-1 (ET-1), a vasoconstrictive 21-amino acid peptide is involved in the muscular oviduct wall contraction [24] . The local distribution of oviductal ET-1 [17] , ET-1 mRNA and mRNA for both A and B receptors types [21] are highest during the follicular and postovulatory phases. Moreover, ET-1 directly stimulates the ovidutal contraction during the follicular and postovulatory phases and thus, it is postulated that the functional ET system in the oviduct is primarily active during the periovulatory period of the estrous cycle [21] . Another vasoconstrictive peptide, angiotensin II (Ang II), was observed to be involved in the autocrine/paracrine regulation of the oviduct [25] . Angiotensin-converting enzyme (ACE) has been found at high concentrations on the epithelial cells of the oviducts of nonpregnant sheep [26] and the ACE activity has also been found in the isthmus of the periovulatory sow oviduct [27] . Moreover, the ACE activity found in the ejaculate may modulate the local generation of Ang II and smooth muscle tonus of the uterus, and the oviduct could facilitate sperm transport [25] . We have recently shown that the bovine oviductal epithelium produces and secretes Ang II [8, 28] and Ang II directly increases the amplitude of oviductal contraction during the periovulatory period [28] . Thus, ET-1 and Ang II participate in the modulation of cyclic oviductal contraction and regulate gamete/embryo transport in the oviduct.
Involvement of TNFα in the Regulation of Cyclic Oviductal Contraction
The oviduct has a capacity to generate PG from both endogenous and exogenous substrate such as arachidonic acid [29] , and PG production in the cow oviduct was stimulated by various substances including luteinizing hormone (LH), E2, ET-1, Ang II and atrial natriuretic peptide [28, [30] [31] [32] . Our resent experiments demonstrated that the infusion of TNFα into microdialyzed cow oviducts collected during the follicular and postovulatory stages clearly stimulated release of PG [8] . Moreover, administration of TNFα significantly increased the production and release of both prostaglandin E2 (PGE2) and PGF2α (PGF2α) by cultured bovine oviductal epithelial cells (BOEC) at both 4 and 24 h after incubation (Unpublished data). It was also reported that the TNFα is known to stimulate both P G E 2 a n d P G F 2 α s e c r e t i o n b y t h e b ov i n e endometrium via the activation of phospholipase A2 (PLA2) and arachidonic acid conversion [33, 34] . TNFα induced PG release in cultured amnion cells [35] , gingival fibroblasts [36] and brain microvessel endothelial cells [37] of human by the activation of cyclooxygenase-2 (COX-2) has also been reporded. Moreover, TNFα-stimulated PGE2 biosynthesis by amnion-derived AV3 cells was accompanied by i nc r e as e d P G H s y n t h as e 2 (P G H S ) m R N A expression [38] . However, the detail mechanism mediating the TNFα-stimulated PG secretion in the cow oviduct has not well studies. Further studies should carry out to clarify this point.
On the other hand, ET caused a concentrationand time-dependent increase in the concentration of TNFα in endothelial cells and bone marrow derived stromal cells of the rat [39] . Also, TNFα stimulated ET-1 release in a time-and dosedependent manner in porcine renal epithelial cell line [40] . Moreover, in our resent observations, TNFα stimulated the ET-1 release from cultured BOEC (unpublished data) and from microdialyzed b o v i n e o v i d u c t d u r i n g t h e f o l l i c u l a r an d postovulatory phases [8] . Therefore, TNFα and ET-1 may interact in a positive feedback manner to elevate their local levels in the oviduct during the periovulatory period of the estrous cycle. The r e s u l t s o f t h e o u r r e s e n t s t u d i e s f u r t h e r demonstrated that TNFα stimulates the release of Ang II into the microdialysed bovine oviduct [8] an d B O E C i n c u lt ur e (u n pu b l is he d d at a) . Moreover, TNFα has been reported to up-regulate type 1 Ang II receptor mRNA and peptide in cultured cardiac fibroblasts [41, 42] . In pregnant rat [43] and ovine [44] uteri Ang II increased PG production. Also, Ang II-stimulated ET-1 release [45] and expression of preproET-1 mRNA by the endothelial cells [46] . We recently observed that Ang II stimulates the secretion of PG and ET-1 in the microdialyzed cow oviduct [28] . Taken together, Ang II appears to be a local intermediator of TNFα that stimulates PG and ET-1 secretion during the periovulatory period, in addition to direct action on oviductal smooth muscle.
Conclusions
On basis of the evidence described above, we propose the following mechanism by which TNFα regulates the bovine oviductal contraction (Fig. 1) . The TNFα originated from the oviductal epithelial cells and the immune cells present in the oviduct may act to module the local release of contraction related substances such as PG, ET-1 and Ang II by the oviductutal epithelial cells. Thus, TNFα might participate in the regulation of cyclic changes in oviductal contraction and may contribute to create an optimal local environment for gamete/embryo transport. Moreover, the ability of embryo to act as a s ourc e o f T NFα in t he o viduct canno t be excluded. The minute quantities of TNFα secreted by the embryo may additively act to enhance the production of PG, ET-1 and Ang II in the oviduct, which may result in an active oviductal contraction in the microenvironment around the embryo. This may ensure the embryo to migrate into the uterus at the optimal time.
Acknowledgement
This study was supported by National Research Council of Sri Lanka (Grant 99-28) and the 21st C e n tu r y C O E P r o g r a m ( A -1 ), M i n i s tr y o f E d u c a t i o n , C u l t u r e , S p o r t s , S c i e n c e a n d T e c h n o l og y , J a p a n . D r . M i ss a k a P . B . Wijayagunawardane is a postdoctoral fellow supported by Japan Society for the Promotion of Science (JSPS). 
